Results 181 to 190 of about 908,413 (222)
Acquired Hemophilia A Associated with Post-Essential Thrombocythemia Myelofibrosis: A Rare Autoimmune Bleeding Complication [PDF]
Turk J HaematolKır S, Patır DÇ, Demirci Z, Şahin F.
europepmc +1 more source
Awareness of Acquired Hemophilia A among Physicians in Japan: A Web-based Survey. [PDF]
JMA JSeki Y, Go M, Ieko M.
europepmc +1 more source
Mixing Test in a Case of Combined Acquired Hemophilia A and Coagulation Factor Deficiency: A Case Report. [PDF]
CureusImataki O +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hematology/Oncology Clinics of North America, 2021
Acquired hemophilia A is a potentially severe bleeding disorder caused by antibodies against the patient's own factor VIII. Acquired hemophilia A is rare. It is most commonly diagnosed in older individuals; about one-half of cases of acquired hemophilia are associated with underlying conditions, including autoimmune disease, cancer, and pregnancy.
Menaka Pai
exaly +3 more sources
Acquired hemophilia A is a potentially severe bleeding disorder caused by antibodies against the patient's own factor VIII. Acquired hemophilia A is rare. It is most commonly diagnosed in older individuals; about one-half of cases of acquired hemophilia are associated with underlying conditions, including autoimmune disease, cancer, and pregnancy.
Menaka Pai
exaly +3 more sources
Hematology, 2006 Acquired hemophilia A is a rare but severe autoimmune bleeding disorder, resulting from the presence of autoantibodies directed against clotting factor VIII. The etiology of the disorder remains obscure, although approximately half of all cases are associated with other underlying conditions.
Massimo Franchini
exaly +3 more sources
Treatment of Acquired Hemophilia A [PDF]
Journal of Thrombosis and Haemostasis, 2007 Acquired hemophilia A (AH) is an autoimmune disease that leads to potentially severe bleeding. Management relies on rapid and accurate diagnosis, control of bleeding episodes and eradication of the inhibitor by immunosuppression. There is extensive literature about the disease but only few controlled data are available.
Peter Collins, P W Collins
exaly +3 more sources
Seminars in Thrombosis and Hemostasis, 2012
Acquired hemophilia A is a rare, autoimmune disorder that is caused by autoantibodies that act as inhibitors to factor VIII. It is characterized by severe, unexpected bleeding that may be life-threatening. The incidence of acquired hemophilia A is ~ 0.2 to 1.48 cases per 1 million individuals per year.
Kathryn E Webert
exaly +3 more sources
Acquired hemophilia A is a rare, autoimmune disorder that is caused by autoantibodies that act as inhibitors to factor VIII. It is characterized by severe, unexpected bleeding that may be life-threatening. The incidence of acquired hemophilia A is ~ 0.2 to 1.48 cases per 1 million individuals per year.
Kathryn E Webert
exaly +3 more sources
Advances in Acquired Hemophilia A
Transfusion Medicine Reviews, 2022Acquired Hemophilia A (AHA) is a rare, life-threatening bleeding disorder from autoantibodies against clotting factor VIII. These autoantibodies occur with increasing incidence with advanced age and are often associated with other medical conditions such as autoimmune diseases and malignancy. Not uncommonly, AHA presents as a new bleeding disorder in a
Jacqueline N Poston +1 more
openaire +2 more sources